Overview

A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Patients That Are Not Helped by Previous Preventive Treatments

Status:
Completed

Trial end date:
2021-10-07

Target enrollment:

Participant gender:

Summary

Evaluation of eptinezumab in the prevention of migraine in patients with unsuccessful prior preventive treatments

Phase:

Phase 3

Details

Lead Sponsor:

H. Lundbeck A/S